載入...
A structure-function approach to optimizing TLR4 ligands for human vaccines
Adjuvants are combined with vaccine antigens to enhance and modify immune responses, and have historically been primarily crude, undefined entities. Introducing toll-like receptor (TLR) ligands has led to a new generation of adjuvants, with TLR4 ligands being the most extensively used in human vacci...
Na minha lista:
| 發表在: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133366/ https://ncbi.nlm.nih.gov/pubmed/27990284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2016.63 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|